1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2:

Clinical outcomes according to type of treatment and presentation

Surgery-Only Group Outcome (mRS Score)Endovascular Group Outcome (mRS Score)P
0, 1, 23, 4, 5, 60, 1, 23, 4, 5, 6
Hunt Hess
    All subjects67.4%32.6%78.9%21.1%.034a
    HH ≤370.0%30.0%84.9%15.1%.006a
    HH ≥459.1%40.9%40.7%59.3%.251
Fisher
    All subjects67%33%77.8%22.2%.054a
    Fisher 1–277.1%22.9%88.8%11.2%.081
    Fisher 3–461.4%38.6%61.1%38.9%.973
  • a Significant.